New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 19, 2014
08:02 EDTIGIGI Laboratories announces fourth ANDA submission in 2014
IGI Laboratories announced it has submitted another abbreviated new drug application to the FDA, which brings the company's total number of ANDA submissions in 2014 to four, with fifteen submissions now pending at the FDA.
News For IG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 30, 2015
16:13 EDTIGIGI Laboratories submits fifth ANDA submission for 2015
IGI Laboratories announced it has submitted its fifth abbreviated new drug application, ANDA, to the FDA of 2015, which brings the Company's total number of ANDA submissions now pending at the FDA to twenty-seven. Jason Grenfell-Gardner, President and CEO of the Company, commented, "We believe our current pipeline of twenty-seven submissions, exclusive of our four partnered submissions, pending approval by the FDA now has a combined addressable market of over $939 million based on May 2015 data from IMS Health. We still expect to submit a total of 20 ANDAs in 2015."

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use